Imaging nerve damage in Guillain-Barré and CIDP
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study uses a special light and sound imaging technique to see inflammation and damage in the nerves of people with Guillain-Barré syndrome or CIDP. It may help doctors better understand and monitor these conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with Guillain-Barré syndrome or CIDP, or your doctor suspects you may have one of these.
- You are willing and able to give written permission to join the study.
- You are not pregnant or breastfeeding.
- You have no tattoos on the area where the imaging will be done.
- Your skin and fat thickness on the imaging area is less than about 1.2 inches.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving immune globulin under the skin (SCIG) can help people with newly diagnosed CIDP. It may help improve muscle strength and nerve symptoms while avoiding the need for earlier IVIG/SCIG treatment.
This trial tests if the drug efgartigimod can help people with Guillain-Barré Syndrome (GBS). If you have had GBS symptoms for less than two weeks and your weakness is moderate to severe, this study may be an option.
This study interviews children who had Guillain-Barré syndrome (GBS) to understand their experiences after recovery. It may help doctors better support young patients with GBS.
This is an observational study that looks at people who were suspected to have Guillain-Barré syndrome and were cared for at University Hospital of Basel in the past. It does not test a new treatment—researchers review existing care to learn more about this condition.
This study tests if ultrasound can find nerve problems in people with Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP), and if it helps doctors diagnose and predict outcomes early.
This study uses ultrasound to see how nerve inflammation changes over time in people with a chronic nerve disease called CIDP. It may help doctors choose the best treatment. The trial includes both newly diagnosed patients and those whose current treatment isn't working well.
Hear when a new CIDP - Chronic Inflammatory Demyelinating Polyneuropathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.